JPH0354106B2 - - Google Patents
Info
- Publication number
- JPH0354106B2 JPH0354106B2 JP56183987A JP18398781A JPH0354106B2 JP H0354106 B2 JPH0354106 B2 JP H0354106B2 JP 56183987 A JP56183987 A JP 56183987A JP 18398781 A JP18398781 A JP 18398781A JP H0354106 B2 JPH0354106 B2 JP H0354106B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- cyanuric chloride
- water
- oxide
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 claims description 17
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 150000001780 cephalosporins Chemical class 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 229930186147 Cephalosporin Natural products 0.000 claims description 4
- 229940124587 cephalosporin Drugs 0.000 claims description 4
- 229930182555 Penicillin Natural products 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229940049954 penicillin Drugs 0.000 claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- 239000002253 acid Substances 0.000 description 11
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- -1 phenolic alcohols Chemical class 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- QILSFLSDHQAZET-UHFFFAOYSA-N diphenylmethanol Chemical compound C=1C=CC=CC=1C(O)C1=CC=CC=C1 QILSFLSDHQAZET-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 235000019371 penicillin G benzathine Nutrition 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ORLCYMQZIPSODD-UHFFFAOYSA-N 1-chloro-2-[chloro(2,2,2-trichloroethoxy)phosphoryl]oxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(=O)OCC(Cl)(Cl)Cl ORLCYMQZIPSODD-UHFFFAOYSA-N 0.000 description 1
- KPWDGTGXUYRARH-UHFFFAOYSA-N 2,2,2-trichloroethanol Chemical compound OCC(Cl)(Cl)Cl KPWDGTGXUYRARH-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- UUPZTFTUZUQRQT-UHFFFAOYSA-N 2-thiophen-2-ylacetamide Chemical compound NC(=O)CC1=CC=CS1 UUPZTFTUZUQRQT-UHFFFAOYSA-N 0.000 description 1
- JKTYGPATCNUWKN-UHFFFAOYSA-N 4-nitrobenzyl alcohol Chemical compound OCC1=CC=C([N+]([O-])=O)C=C1 JKTYGPATCNUWKN-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000005826 halohydrocarbons Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical class [H]C([H])([H])* 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Description
【発明の詳細な説明】
本発明は遊離のカルボキシ基を有するペニシリ
ン,セフアロスポリンまたはその誘導体に塩基お
よび塩化シアヌルの存在下に0〜−35℃の温度で
アルコールを作用させて対応するエステルを製造
する方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention involves reacting penicillin, cephalosporin, or a derivative thereof having a free carboxyl group with an alcohol in the presence of a base and cyanuric chloride at a temperature of 0 to -35°C to produce the corresponding ester. Regarding the method.
ここにペニシリンまたはその誘導体は6位にア
シルアミド基、アルキル基などを有し、かつ3α
位などにカルボキシ基を有する化合物であつて、
要すればペナム環上に二重結合、アルキル基、ア
ルキレン基、置換チオ基などを有していてもよ
く、また、硫黄原子がスルホキシド、スルホン、
酸素原子、メチレンなどと交換してあつてもよい
ものとする。 Here, penicillin or its derivatives have an acylamido group, an alkyl group, etc. at the 6-position, and 3α
A compound having a carboxy group at the position etc.
If necessary, the penum ring may have a double bond, an alkyl group, an alkylene group, a substituted thio group, etc., and the sulfur atom may have a sulfoxide, sulfone,
It may be exchanged with oxygen atom, methylene, etc.
また、セフアロスポリンまたはその誘導体とし
ては7位にアシルアミド側鎖を有し、3位は非置
換であるか、いわゆる求核基であるか、あるいは
求核基置換メチルであり、かつ4位または他の位
置にカルボキシ基を有する化合物であつて、要す
ればセフアロスポリン骨格上の硫黄原子がスルホ
キシド、スルホン、酸素原子、メチレンなどと交
換してあつてもよいものとする。 In addition, cephalosporin or its derivatives have an acylamide side chain at the 7-position, the 3-position is unsubstituted, a so-called nucleophile, or a nucleophile-substituted methyl, and the 4-position or other It is a compound having a carboxy group at a position, and if necessary, the sulfur atom on the cephalosporin skeleton may be replaced with a sulfoxide, sulfone, oxygen atom, methylene, etc.
前記のアシルアミドはいわゆるβ−ラクタム抗
生物質の化学において公知のアシルアミド基はす
べて含まれるものとする。 The above-mentioned acylamides include all acylamide groups known in the chemistry of so-called β-lactam antibiotics.
アルコールとしては、酸の反応性誘導体と反応
してエステルを形成し得るものであれば、どのよ
うなものでよく、実際にアルカノール、アラルカ
ノール、フエノール性アルコールのいずれについ
ても反応は円滑に進行することが証明されてい
る。 Any alcohol can be used as long as it can react with a reactive derivative of an acid to form an ester, and the reaction proceeds smoothly with alkanols, aralkanols, and phenolic alcohols. It has been proven that.
塩基としては、第三級アミン(トリアルキルア
ミン、ジメチルアニリンなど)や芳香族塩基(ピ
リジン、ピコリン、ルチジン、キノリンなど)が
好適に用いられる。 As the base, tertiary amines (trialkylamine, dimethylaniline, etc.) and aromatic bases (pyridine, picoline, lutidine, quinoline, etc.) are preferably used.
この反応の原料物質、生成物は公知物質または
その近縁化合物であつて、抗菌剤など、有用化合
物の合成原料として有用である。 The raw materials and products of this reaction are known substances or their closely related compounds, and are useful as raw materials for the synthesis of useful compounds such as antibacterial agents.
塩化シアヌルをアシル化試薬として用いる方法
は、アミド化に関しては多数の報告があり、エス
テル化に関する報告も散見される。しかし、この
発明の主題である分野については適用例の報告が
ない。 Regarding the method of using cyanuric chloride as an acylation reagent, there are many reports regarding amidation, and there are also reports regarding esterification. However, there are no reports of applications in the field that is the subject of this invention.
先行文献は、いずれも高温の反応であるが、本
発明者の実験では低温でないと分解のため収率低
下を示し、工業上利用できないことが判明した。
また、塩基の量が4当量以上ないと収率低下を招
くことが実証された。 All of the prior documents involve high-temperature reactions, but experiments by the present inventors have shown that unless the temperature is low, the yield decreases due to decomposition, making them industrially unusable.
Furthermore, it has been demonstrated that if the amount of base is not 4 equivalents or more, the yield decreases.
前述の如く、この発明を実施するには、エステ
ル化すべきカルボン酸化合物、アルコール、塩基
および塩化シアヌルを、好ましくは溶媒中で混合
する。 As previously mentioned, to practice this invention, the carboxylic acid compound to be esterified, the alcohol, the base, and cyanuric chloride are mixed, preferably in a solvent.
溶媒としては工業上利用できる不活性有機溶媒
または前記アルコールまたは塩基の過剰量をこれ
にあてることができる。ハロ炭化水素、ニトリ
ル、アセトン、エーテル、アルコール系などの有
機溶媒が用いられることも実証してある。 As solvents, industrially available inert organic solvents or excess amounts of the alcohols or bases mentioned above can be used. It has also been demonstrated that organic solvents such as halohydrocarbons, nitriles, acetones, ethers, and alcohols can be used.
好ましくは0.5〜1.5モルの塩化シアヌル、3〜
8モルの塩基、1.0モル以上のアルコールを用い、
−35℃〜室温の場合、0.5時間ないし24時間反応
させれば目的とするエステルを製造できる。 Preferably 0.5-1.5 mol cyanuric chloride, 3-
Using 8 mol of base and 1.0 mol or more of alcohol,
In the case of -35°C to room temperature, the desired ester can be produced by reacting for 0.5 to 24 hours.
このようにして製造したエステルに濃縮、
過、抽出、再結晶など、常法により容易に取得す
ることができる。 The ester produced in this way is concentrated,
It can be easily obtained by conventional methods such as filtration, extraction, and recrystallization.
本発明の生成物は各種セフアロスポリンなどの
合成中間体として有用である。 The products of the present invention are useful as synthetic intermediates for various cephalosporins and the like.
以下に実施例を示して本発明の態様を説明す
る。 Embodiments of the present invention will be explained below with reference to Examples.
実施例 1
(a) 7β−(2−チエニルアセトアミド)セフアロ
スポラン酸1.2gをメタノール12mlにとかし、−
15℃に冷却下、ピリジン1.3gと塩化シアヌル
0.75gとを加え、0.5時間かきまぜる。反応液
を水中に注入し、析出する結晶を取し、水
洗、乾燥する。これをメタノール−エーテル混
液から再結晶すれば7β−(2−チエニルアセト
アミド)セフアロスポラン酸メチルエステル
1.0gを得る。mp180〜184℃。Example 1 (a) 1.2 g of 7β-(2-thienylacetamido)cephalosporanic acid was dissolved in 12 ml of methanol, -
1.3g of pyridine and cyanuric chloride while cooling to 15℃
Add 0.75g and stir for 0.5 hour. The reaction solution is poured into water, and the precipitated crystals are collected, washed with water, and dried. If this is recrystallized from a methanol-ether mixture, 7β-(2-thienylacetamido)cephalosporanic acid methyl ester is obtained.
Obtain 1.0g. mp180~184℃.
(b) 7β−(2−チエニルアセトアミド)セフアロ
スポラン酸1.2gと2,2,2−トリクロロエ
タノール2mlとをアセトニトリル7mlにとか
し、−20℃に冷却下、ピリジン1.3mlと塩化シア
ヌル0.75gを加えて、1.5時間かきまぜる。反
応液を水中に注ぎ、析出する結晶を取し、水
洗、乾燥後、エーテルから再結晶すれば7β−
(2−チエニルアセトアミド)セフアロスポラ
ン酸2,2,2−トリクロロエチルエステル
1.4gを得る。mp117.5〜120℃。(b) Dissolve 1.2 g of 7β-(2-thienylacetamido)cephalosporanic acid and 2 ml of 2,2,2-trichloroethanol in 7 ml of acetonitrile, and add 1.3 ml of pyridine and 0.75 g of cyanuric chloride while cooling to -20°C. , stir for 1.5 hours. Pour the reaction solution into water, collect the precipitated crystals, wash with water, dry, and recrystallize from ether to obtain 7β-
(2-thienylacetamide)cephalosporanic acid 2,2,2-trichloroethyl ester
Obtain 1.4g. mp117.5~120℃.
(c) 7β−(2−チエニルアセトアミド)セフアロ
スポラン酸1.2gとベンジルアルコール1.5mlと
をアセトン10mlにとかし、氷冷下にピリジン
1.3mlと塩化シアヌル0.7gとを加えて5時間か
きまぜる。反応液を氷水中に注ぎ、析出する結
晶を取し、水洗、乾燥する。生成物をエーテ
ルから再結晶すれば7β−(2−チエニルアセト
アミド)セフアロスポラン酸ベンジルエステル
1.2gを得る。mp145.5〜147℃。(c) Dissolve 1.2 g of 7β-(2-thienylacetamido)cephalosporanic acid and 1.5 ml of benzyl alcohol in 10 ml of acetone, and add pyridine under ice cooling.
Add 1.3 ml and 0.7 g of cyanuric chloride and stir for 5 hours. Pour the reaction solution into ice water, collect the precipitated crystals, wash with water, and dry. Recrystallization of the product from ether yields 7β-(2-thienylacetamido)cephalosporanic acid benzyl ester.
Obtain 1.2g. mp145.5~147℃.
実施例 2
ベンジルペニシリン1.2gおよびベンズヒドロ
ール0.8gをジクロロメタン10mlにとかし、−10℃
に冷却下、これにピリジン1.2gと塩化シアヌル
1.0gとを加えて5時間反応させる。反応液を水
洗、乾燥、乾固し、残留物をアセトンから再結晶
すればベンジルペニシリン・ベンズヒドリルエス
テル1.5gを得る。mp111.5〜112.5℃。Example 2 1.2 g of benzylpenicillin and 0.8 g of benzhydrol were dissolved in 10 ml of dichloromethane and heated to -10°C.
While cooling, add 1.2 g of pyridine and cyanuric chloride to this.
1.0g and reacted for 5 hours. The reaction solution was washed with water, dried, and dried to dryness, and the residue was recrystallized from acetone to obtain 1.5 g of benzylpenicillin benzhydryl ester. mp111.5~112.5℃.
実施例 3
6β−フエニルアセトアミドペニシラン酸・1β
−オキシド0.43gとベンズヒドロール0.27gをジ
クロロメタン2mlにとかし、−35℃でピリジン
0.41mlと塩化シアヌル0.3gとを加えて5時間反
応させる。反応液を水洗、乾燥、乾固し、残留物
をアセトンから再結晶すれば6β−フエニルアセ
トアミドペニシラン酸ベンズヒドリルエステル・
1β−オキシド0.76gを得る。mp82〜86℃。Example 3 6β-phenylacetamidopenicillanic acid 1β
- Dissolve 0.43 g of oxide and 0.27 g of benzhydrol in 2 ml of dichloromethane, and add pyridine at -35°C.
Add 0.41 ml and 0.3 g of cyanuric chloride and react for 5 hours. The reaction solution is washed with water, dried, and dried, and the residue is recrystallized from acetone to obtain 6β-phenylacetamidopenicillanic acid benzhydryl ester.
0.76 g of 1β-oxide is obtained. mp82~86℃.
実施例 4
6β−p−トリオイルアミノペニシラン酸・1β
−オキシド1.2gをメタノール10mlにとかし、氷
冷下ピリジン1.5mlと塩化シアヌル0.8gのクロロ
ホルム溶液10mlを加えたのち、2時間かきまぜ
る。反応液を氷水に注ぎ、析出する結晶を取
し、水とメタノールで洗浄すれば6β−p−トル
オイルアミノペニシラン酸メチルエステル・1β
−オキシド1.1gを得る。mp152〜154℃。Example 4 6β-p-trioylaminopenicillanic acid 1β
- Dissolve 1.2 g of oxide in 10 ml of methanol, add 1.5 ml of pyridine under ice cooling and 10 ml of a chloroform solution of 0.8 g of cyanuric chloride, and stir for 2 hours. Pour the reaction solution into ice water, collect the precipitated crystals, and wash with water and methanol to obtain 6β-p-toluoylaminopenicillanic acid methyl ester 1β.
-1.1 g of oxide are obtained. mp152~154℃.
実施例 5
6β−ベンズアミドペニシラン酸・1β−オキシ
ド1.0gとベンズヒドロール0.7gとをアセトニト
リル20mlとピリジン2mlとの混液にとかし、−10
℃に保ちつつ塩化シアヌル0.7gを加えて2時間
かきまぜる。反応液を氷水に注ぎ、30分間かきま
ぜる。析出する結晶を減圧過し、水とメタノー
ル少量で洗い、乾燥すれば6β−ベンズアミドペ
ニシラン酸ベンズヒドリルエステル・1β−オキ
シド1.5gを得る。mp151〜153℃。Example 5 1.0 g of 6β-benzamidopenicillanic acid 1β-oxide and 0.7 g of benzhydrol were dissolved in a mixture of 20 ml of acetonitrile and 2 ml of pyridine, and -10
Add 0.7 g of cyanuric chloride and stir for 2 hours while maintaining the temperature at °C. Pour the reaction mixture onto ice water and stir for 30 minutes. The precipitated crystals are filtered under reduced pressure, washed with water and a small amount of methanol, and dried to obtain 1.5 g of 6β-benzamidopenicillanic acid benzhydryl ester 1β-oxide. mp151~153℃.
実施例 6
6β−p−トリオイルアミノペニシラン酸・1β
−オキシド1.3gとピリジン1.22gとをジクロロ
メタン30mlにとかし、−30℃に冷却下にp−クレ
ゾール0.8gと塩化シアヌル0.9gとを加えて1時
間かきまぜる。反応液を水洗、乾燥後、減圧濃縮
する。残留物をシリカゲル・クロマトグラフイー
により精製し、目的物を含有する部分を集め、シ
クロロメタン−メタノール混液から再結晶すれば
6β−p−トルオイルアミノペニシラン酸p−ト
ルイルエステル・1β−オキシド1.5gを得る。
mp162.5〜164℃。Example 6 6β-p-trioylaminopenicillanic acid 1β
- Dissolve 1.3 g of oxide and 1.22 g of pyridine in 30 ml of dichloromethane, add 0.8 g of p-cresol and 0.9 g of cyanuric chloride while cooling to -30°C, and stir for 1 hour. The reaction solution is washed with water, dried, and concentrated under reduced pressure. Purify the residue by silica gel chromatography, collect the part containing the target product, and recrystallize it from a cyclomethane-methanol mixture.
1.5 g of 6β-p-toluoylaminopenicillanic acid p-tolyl ester 1β-oxide is obtained.
mp162.5~164℃.
実施例 7
6α−フエノキシアセトアミドペニシラン酸1β
−オキシド1.1gとp−ニトロベンジルアルコー
ル0.7gとをジクロロメタン10mlにとかし、氷冷
下にピリジン4mlと塩化シアヌル0.7gとを加え
て4時間かきまぜる。反応液を水洗、乾燥、濃縮
する。残留物をアセトン−エーテル混液から結晶
化させれば6α−フエノキシアミドペニシラン酸
p−ニトロベンジルエステル・1β−オキシド0.9
gを得る。mp137〜138℃。Example 7 6α-phenoxyacetamidopenicillanic acid 1β
- Dissolve 1.1 g of oxide and 0.7 g of p-nitrobenzyl alcohol in 10 ml of dichloromethane, add 4 ml of pyridine and 0.7 g of cyanuric chloride under ice cooling, and stir for 4 hours. The reaction solution is washed with water, dried, and concentrated. If the residue is crystallized from an acetone-ether mixture, 6α-phenoxyamidopenicillanic acid p-nitrobenzyl ester 1β-oxide 0.9
get g. mp137-138℃.
実施例 8
6α−ベンズアミドペニシラン酸・1β−オキシ
ド1.2gとベンジルアルコール0.7gとをジクロロ
メタン7mlにとかし、氷冷、撹拌下、トリエチル
アミン3.0mlと塩化シアヌル1.5gとを加えたのち
2時間かきまぜる。反応液を水洗、乾燥し、減圧
下に濃縮乾固する。残留物をジクロロメタン−エ
ーテル混液から再結晶すれば6α−ベンズアミド
ペニシラン酸ベンジルエステル・1β−オキシド
1.3gを得る。mp118〜120℃。Example 8 1.2 g of 6α-benzamidopenicillanic acid/1β-oxide and 0.7 g of benzyl alcohol are dissolved in 7 ml of dichloromethane, and 3.0 ml of triethylamine and 1.5 g of cyanuric chloride are added under ice cooling and stirring, followed by stirring for 2 hours. The reaction solution was washed with water, dried, and concentrated to dryness under reduced pressure. Recrystallizing the residue from a dichloromethane-ether mixture yields 6α-benzamidopenicillanic acid benzyl ester/1β-oxide.
Obtain 1.3g. mp118~120℃.
実施例 9
6α−p−クロロベンズアミドペニシラン酸・
1β−オキシド1.0gとベンズヒドロール0.7gとを
アセトニトリル20mlとピリジン2mlとの混液にと
かし、−10℃に保ちつつ塩化シアヌル0.7gを加え
て2時間かきまぜる。析出する結晶を取し、水
洗、乾燥すれば6α−p−クロロベンズアミドペ
ニシラン酸ベンズヒドリルエステル・1β−オキ
シド1.5gを得る。mp166〜168℃。Example 9 6α-p-chlorobenzamide penicillanic acid.
Dissolve 1.0 g of 1β-oxide and 0.7 g of benzhydrol in a mixture of 20 ml of acetonitrile and 2 ml of pyridine, add 0.7 g of cyanuric chloride while keeping the temperature at -10°C, and stir for 2 hours. The precipitated crystals are collected, washed with water, and dried to obtain 1.5 g of 6α-p-chlorobenzamide penicillanic acid benzhydryl ester 1β-oxide. mp166~168℃.
実施例 10
7β−ベンズアミド−7α−メトキシ−3,3−
メチレン−1−デチア−1−オキサセフアム−
4μ−カルボン酸0.76gとベンズヒドロール0.93g
とをジオキサン5mlにとかし、これにピリジン
0.38gと塩化シアヌル0.29gを−5℃下に加え、
同温で1時間かきまぜる。反応液を氷水中に注
ぎ、かきまぜたのち、析出する結晶を取、水
洗、乾燥する。残留物をジクロロメタン−エーテ
ル混液から再結晶すれば7β−ベンズアミド−7α
−メトキシ−3,3−メチレン−1−デチア−1
−オキサセフアム−4α−カルボン酸ベンズヒド
リルエステル1.08gを得る。mp196〜198℃。Example 10 7β-benzamide-7α-methoxy-3,3-
Methylene-1-dethia-1-oxacefam-
4μ-carboxylic acid 0.76g and benzhydrol 0.93g
Dissolve in 5 ml of dioxane and add pyridine to this.
Add 0.38g and 0.29g of cyanuric chloride at -5℃,
Stir at the same temperature for 1 hour. After pouring the reaction solution into ice water and stirring, the precipitated crystals are collected, washed with water, and dried. Recrystallizing the residue from a dichloromethane-ether mixture yields 7β-benzamide-7α.
-methoxy-3,3-methylene-1-dethia-1
-Oxacefam-4α-carboxylic acid benzhydryl ester 1.08 g is obtained. mp196~198℃.
Claims (1)
フアロスポリンまたはその誘導体に、塩基および
該カルボキシ基含有化合物1モル当り0.7〜1.5モ
ルの塩化シアヌルの存在下、−35℃〜0℃の温度
でアルコールを作用させて、対応するエステルを
製造する方法。1 Penicillin, cephalosporin or a derivative thereof having a free carboxyl group is reacted with alcohol at a temperature of -35°C to 0°C in the presence of a base and 0.7 to 1.5 mol of cyanuric chloride per 1 mol of the carboxyl group-containing compound. , a method for preparing the corresponding esters.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56183987A JPS5885891A (en) | 1981-11-16 | 1981-11-16 | Esterification of beta-lactam antibiotic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56183987A JPS5885891A (en) | 1981-11-16 | 1981-11-16 | Esterification of beta-lactam antibiotic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5885891A JPS5885891A (en) | 1983-05-23 |
JPH0354106B2 true JPH0354106B2 (en) | 1991-08-19 |
Family
ID=16145327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56183987A Granted JPS5885891A (en) | 1981-11-16 | 1981-11-16 | Esterification of beta-lactam antibiotic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5885891A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100485364B1 (en) * | 2002-09-18 | 2005-04-27 | 종근당바이오 주식회사 | Halogenation of cephalosporin |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55122727A (en) * | 1979-03-16 | 1980-09-20 | Nippon Iyakuhin Kaihatsu Kenkyusho:Kk | Acylation |
-
1981
- 1981-11-16 JP JP56183987A patent/JPS5885891A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55122727A (en) * | 1979-03-16 | 1980-09-20 | Nippon Iyakuhin Kaihatsu Kenkyusho:Kk | Acylation |
Also Published As
Publication number | Publication date |
---|---|
JPS5885891A (en) | 1983-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH02311483A (en) | Preparation of ceftriaxone | |
US4699980A (en) | Process for preparing 3-substituted-methyl-3-cephem derivatives | |
JPH0560473B2 (en) | ||
JPS6360992A (en) | Novel oxime derivative of 3-substituted 7-aminothiazolylacetamide cephalosporinic acid | |
KR920005830B1 (en) | Process for preparing amino-hydroxy cepham carboxylates | |
JP2939129B2 (en) | Intermediates in the synthesis of cephalosporins | |
JPH0354106B2 (en) | ||
US4237279A (en) | Crystalline 3-hydroxycephalosporin solvates | |
US4281117A (en) | Process for 3-chloro cephalosporin nucleus | |
US4497956A (en) | Manufacture of antibiotics | |
EP0117872B1 (en) | Process for preparing cephalosporin compounds | |
JPS60202891A (en) | Catalytic process for manufacturing 3-ester methylcephalosporins from desacetyl-7-aminocephalosporanic acid | |
US4092476A (en) | Phthalidyl esters of 7-[(α amino, 2 substituted acetamido)-3-(heterocyclic-thio methyl)]cephalosporins | |
JPH11124384A (en) | Production of 3-cephem compound | |
CS203983B2 (en) | Method of preparing ester of 7-acylamido-3-methyl-3-cephem-4-carboxylic acid | |
FI68239C (en) | KRISTALLINA 3-HYDROXICEPHALOSPORINSOLVAT SOM AER MELLANPRODUKTER VID FRAMSTAELLNING AV 3-HYDROXICEFALOSPORINER ANVAENDBARA SOM MELLANPRODUKTER VID FRAMSTAELLNING AV CEFALOSPORINER OCHFOERFARANDO F | |
US4183850A (en) | Process for preparing 2-acyloxymethylpenams and 3-acyloxycephams | |
US3994888A (en) | Cephalosporin cleavage process | |
JPH0358351B2 (en) | ||
US4091214A (en) | De-esterification process for cephalosporins | |
JPS5951555B2 (en) | Method for producing cephalosporin compounds | |
US4001239A (en) | Cephalosporin cleavage process | |
KR800000412B1 (en) | Process for preparation of cephalosporin esters | |
JPS6219431B2 (en) | ||
US4835267A (en) | Process for the preparation of cephalosporin derivatives |